Donor-Derived Smoldering Multiple Myeloma following a Hematopoietic Cell Transplantation for AML
Posttransplant Lymphoproliferative Disorder (PTLD) is one of the most common malignancies complicating solid organ transplantation. In contrast, PTLD accounts for a minority of secondary cancers following allogeneic hematopoietic cell transplantation (HCT). Here we report on a 61-year-old woman who...
Main Authors: | Bita Fakhri, Mark Fiala, Michael Slade, Peter Westervelt, Armin Ghobadi |
---|---|
Format: | Article |
Language: | English |
Published: |
Hindawi Limited
2017-01-01
|
Series: | Case Reports in Hematology |
Online Access: | http://dx.doi.org/10.1155/2017/3728429 |
Similar Items
-
Smoldering Multiple Myeloma
by: Minjie Gao, et al.
Published: (2015-01-01) -
The Role of Monoclonal Antibodies in Smoldering and Newly Diagnosed Transplant-Eligible Multiple Myeloma
by: E. Zamagni, et al.
Published: (2020-12-01) -
Genomic patterns of progression in smoldering multiple myeloma
by: Niccolò Bolli, et al.
Published: (2018-08-01) -
What Is New in the Treatment of Smoldering Multiple Myeloma?
by: Niccolo’ Bolli, et al.
Published: (2021-01-01) -
Systemic Mastocytosis Associated with “Smoldering” Multiple Myeloma
by: Magda Zanelli, et al.
Published: (2021-01-01)